Loading clinical trials...
Loading clinical trials...
The ARIES C. difficile Assay is a real-time PCR based qualitative in vitro diagnostic test for the direct detection of C. difficile nucleic acid in stool specimens.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Luminex Corporation
NCT05199532 · Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, and more
NCT05219903 · Eosinophilic Gastrointestinal Disorders, Eosinophilic Esophagitis, and more
NCT04471493 · Otitis, Bronchiolitis, and more
NCT06579170 · Gastroenteritis, Gastrointestinal Diseases, and more
NCT07342088 · Infectious Diarrhea, Acute Gastroenteritis
Tampa General Hospital
Tampa, Florida
Indiana University Health
Indianapolis, Indiana
TriCore Reference Laboratories
Albuquerque, New Mexico
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions